5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Acutaas Chemicals Ltd.

•
acutaas.comBSE: 543349NSE: ACUTAAS
Market Cap₹ 27,651 Cr.
Current Price
High / Low₹ 3,740 / 1,302
Stock P/E71.6
Book Value₹ 211
Price to Book12.69
Dividend Yield0.07 %
ROCE32.4 %
ROE24.1 %
Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 45.8% CAGR over last 5 years
  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 21.5%
  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 70.4% YoY, showing strong momentum
  • Company has delivered good sales growth of 31.5% CAGR over last 5 years

CONS

  • Promoter holding has decreased over last 2 years: -3.3pp
  • Total debt has risen sharply - up 223.7% year on year
  • Stock is trading at 12.7x its book value
  • Equity base is being diluted - shares outstanding up 12.3%
  • Though reporting repeated profits, the company pays out little dividend (5.7%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.ACUTAAS3377.3571.5927650.740.0774.9970.40329.6859.0832.4234.30
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
154172166225177247275308207306393433330
120148140182147198206224156211243249228
Operating Profit34252743304969855195151184102
OPM %22.12%14.40%15.93%19.19%16.71%19.83%24.97%27.54%24.57%31.13%38.32%42.41%30.97%
1-3031182616105112
Interest1132401111111
Depreciation4445676788101010
Profit before Tax31-102437205063835896145184104
Tax %28.12%-71.23%24.85%30.99%26.40%24.92%28.25%24.29%24.23%25.29%26.58%26.94%27.83%
Net Profit000015384563447210613475
6.10-4.674.583.431.834.695.687.805.418.8213.1916.099.07

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1601882392403415206177171,0071,3391,462
137158196199260415494589775859930
Operating Profit2331424180105123128232480532
OPM %14.43%16.21%17.64%17.12%23.53%20.22%19.88%17.91%23.05%35.87%36.37%
0303134-25174227
Interest33566626634
Depreciation12344101216273638
Profit before Tax19283535729111282216483529
Tax %35.51%34.75%33.65%20.96%24.72%21.33%25.75%40.53%25.79%26.18%26.72%
Net Profit1218232754728349160356387
EPS80.32123.307.408.7217.1421.0322.8611.6019.3943.51—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%15.19%13.12%25.87%7.74%5.75%—

COMPOUNDED SALES GROWTH

10 Years:
24%
5 Years:
32%
3 Years:
29%

COMPOUNDED PROFIT GROWTH

10 Years:
40%
5 Years:
46%
3 Years:
62%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
130%

RETURN ON EQUITY

10 Years:
26%
5 Years:
17%
3 Years:
16%
Last Year:
24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Sep 17

₹ 0.50

Rs.2.5000 per share(50%)Final Dividend

2025

Sep 18

₹ 0.30

Rs.1.5000 per share(30%)Final Dividend

2024

Sep 13

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2023

Sep 18

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2022

Jul 29

₹ 0.30

Rs.3.0000 per share(30%)Final Dividend

2026

Sep 7

₹ 0.50

Rs.2.5000 per share(50%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital221010323636374141
Minority Interest000000091057
3756721011354865586351,2691,610
24414854117131861336
Trade Payables3848685185118142135156154
891415441828956087
Total Liabilities1091552132324136597671,0961,5491,984
28327985186205259427570745
Capital Work in Progress11302120226125130332
1322122000
2027395260112119157180231
0000000206290363
Cash & Bank410431005953249225
4562927716223930312712988
Total Assets1091552132324136597671,0961,5491,984

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
35162935421190125118292
Cash from Investing-19-25-21-24-101-121-33-365-224-266
Cash from Financing-7156072140-122392614
3-2-03-1820-115630

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
35.9835.9735.9635.9632.6632.6632.6632.6632.66
12.9313.8715.5216.4816.9416.8416.6719.4821.61
14.8119.9320.2318.3122.3822.5921.7019.6019.55
0.000.000.010.010.010.010.010.010.01
36.2930.2328.2729.2328.0127.8928.9628.2426.16

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
General Updates

2026-09-10 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-09-04
General Updates

2026-09-04 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-31
Copy of Newspaper Publication

2026-08-31 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29
General Updates

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-29
Record Date

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Sep-2026.

2026-08-29
Shareholders meeting

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-28
Press Release

2026-08-28 - Acutaas Chemicals Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Acutaas Chemicals step-down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju, The Republic of Korea".

2026-08-24
Copy of Newspaper Publication

2026-08-24 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-22
General Updates

2026-08-22 - Acutaas Chemicals Limited has informed the Exchange about General Updates

News

Recent coverage and analyst commentary for ACUTAAS

Loading news…

🤖

AI Stock Analyst

Acutaas Chemicals Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login